Marilyn E. Wortzman is VP & Finance at Transcept Pharmaceuticals Inc (TSPT). They have made 2 open-market trades across 1 company since 2006, most recently 2012-04-16.
CIK 0001235962
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TSPT | SELL · 10b5-1 | 2012-04-16 | 2012-04-17 | $11.40 | $52K | N/A | N/A | N/A |
| TSPT | SELL · 10b5-1 | 2012-03-19 | 2012-03-20 | $10.00 | $92K | N/A | N/A | N/A |
| TSPT | SELL · 10b5-1 | 2011-10-04 | 2011-10-05 | $8.00 | $32K | N/A | N/A | N/A |
| TSPT | SELL · 10b5-1 | 2011-06-15 | 2011-06-15 | $10.11 | $40K | N/A | N/A | N/A |
| TSPT | SELL · 10b5-1 | 2011-03-15 | 2011-03-16 | $8.17 | $33K | N/A | N/A | N/A |
| TSPT | SELL · 10b5-1 | 2011-01-07 | 2011-01-10 | $8.00 | $64K | N/A | N/A | N/A |
| ONXX | SELL | 2006-02-22 | 2006-02-24 | $28.02 | $280K | N/A | N/A | N/A |
| ONXX | SELL | 2006-01-19 | 2006-01-20 | $27.71 | $197K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.